Showing posts with label ALK mutation. Show all posts
Showing posts with label ALK mutation. Show all posts

Tuesday, May 25, 2010

Sitting Here In Limbo

Just to let you know how things are going around these parts, well, uh, we don't know quite yet.  The surgery was the 13th of May, the tissue from the malignant node was sent to UW thereafter, and the results are not back yet.  Waiting is excruciating.  Let me tell you a little story why.

I'm on several internet sites that are out there for folks who have been diagnosed with lung cancer.  One site, http://www.cancergrace.org/ is excellent--organized and run by oncologists.  Another site, http://www.inspire.com/  is more touchy feely and overrun with folks who are determined to talk about and praise homeopathic and naturopathic treatments. Many of the more recent members in this lung cancer lounge have very little good to say about big Pharma or the established medical profession.  It wasn't always like this when I first joined inspire back in January, but in the past 3 months the voices of the Gerson and laetrile advocates have been drowning out those like me who are supporters of traditional allopathic medicine  and who think that medical treatments need to be rigorously tested before being prescribed.  

But given the current survival rates for lung cancer, it feels a lot like whistling past the graveyard.  Because even where there is positive response to lung cancer treatment, these results are measured in days.  Take a look at the conclusions in a good article written about what happens when you drop the dosage of Iressa or Tarceva in patients whose tumors are responding but the patients are suffering from bad side effects.  This is found at cancergrace and was written to give the lay person a better understanding of recent research in the field, by Seattle oncologist, Dr. Jack West, one of the best lung cancer specialists around:

The retrospective analysis compares the results of 52 (46%) of patients who continued at full dose Iressa with the 62 (54% (!!)) who had a dose-reduction of Iressa, generally switching to once every two day treatment (because there are no lower dose tablets of gefitinib than 250 mg).


The analysis showed no significant difference at all in outcomes, and even a numerically longer median progression-free survival of 351 days vs. 301 days, and median overall survival of 928 days vs. 852 days, for the lower dose vs. full dose recipients, respectively.


This doesn’t mean that lower dosing is a superior strategy (these are not close to statistically significant differences, and the groups aren’t huge), but it should allay anyone’s fears that the people who need to reduce dose of their EGFR inhibitor due to challenging side effects are compromising their treatment — at least for patients who have tumors with an EGFR mutation.
http://cancergrace.org/lung/2010/05/24/dose-vs-efficacyof-egfr-tki/

So, in the best case scenario, where the drug is working to suppress the cancer the median overall survival rate is less than three years! 

Lung cancer is an implacable foe, one that does not rest.  It seems immune to most of our current treatment regimens.  And I think this is the cause of much of the hysteria and the adoption of unproven and dangerous treatments by many lung cancer patients, not just those on inspire. Early on in my time online with inspire, I made the acquaintanceship of a very nice young fellow named Joe.  He was 24 and his mom had been diagnosed with late stage lung cancer.  She died on May 22, 2010, 15 months after her diagnosis.  She was my age or younger from what I can tell.  This is normal for the course of the lung cancer.  But, naturally, Joe is devastated.  15 months.  It's like compressing the next 20+ years that I thought I would have, into less than 2.  And 8 months have gone by so far for me.  I try not to go there and refuse to think about what effect my disease progression and death will have on my own children, who are 24, 23 and 20. 

At present, I have no treatment for my lung cancer.  There is no radiation or chemotherapy scheduled or any prescribed drugs.  I am simply waiting for the EGFR results to come back before new plans can be made.  And if the EGFR results are negative, plans will still have to wait because then I have to go through an additional set of tests for the ALK mutation, and they can also take quite a bit of time.  Finally, the chances that I will have the ALK mutation, despite Dr. M's optimism, remains very slim.  Only 3-4% of the population of lung cancer sufferers have this mutation.  But the drug results are so incredibly positive that it would be foolish not to try for it.  Again, hope winning out over reality.  But this time, it is in the context of a medical treatment that has solid clinical results underpinning its use.

If I don't qualify for the ALK meds, then I will have to consider other less fun options for my plan.  Like more chemotherapy using other drugs, or radiation to the tumors.  Both of these are severe treatments which also do not have very good returns on them.  But they are something.  And this something has been determined to be better than nothing.  At least for now.

What this all boils down to, is that my life has been reduced to a series of trade offs.  In exchange for hopefully, additional months of life, I give up my sense of taste, my hearing, and my peripheral sensations to take chemotherapy.  I give up my clear, normal skin, and thick hair to take the Tarceva, also supposedly for additional months. I have an operation on my paralyzed vocal cord, and it gives me back half a voice but I've still lost my ability to sing.  A malignant lymph node is surgically removed for testing, and I am left with a shoulder that is numb and exquisitely painful around the edges.  Although this numbness should be temporary, it's been 12 days now.  As the disease progresses, the trade offs will become more dire.  Eventually there will be nothing more to trade off.  Basically, this is the normal aging process on steroids. 

This is why waiting sucks big time right now.  Because there is no big time left.

Friday, May 07, 2010

The Second, Second Opinion at Seattle Cancer Care

My daughter made it home safely last night and went with me to SCCA where we were joined by my friend, Diane.

Rather than rewrite what happened, here is the letter I sent to three of the Group Health oncologists following our appointment (and after a celebratory brunch at Portage Bay Cafe).  Edited to note that the primary author was my daughter so that I got the medicine right--Thanks dear!

Dear Drs. C***, F****** and C*******:

I am writing to update you on my meeting today with Dr. R***** M***** at SCCA. Dr. M***** reviewed the medical records GH sent over yesterday, which were requested Monday. Unfortunately, the latest ct scan read from April was not included in the records, but luckily I had printed a copy and was able to provide it to Dr. M***** during our appointment.

Based upon his review of the records, and his examination, Dr. M***** recommended that I discontinue taking the Tarceva tomorrow. The substantial increase in tumor size coupled with the toxicity, particularly on my legs and arms, led him to the conclusion that I had failed second line therapy with Tarceva at this point, or at the very least, the toxicity far outweighs the observable benefits at this point.

Dr. M***** indicated that he would like me to pursue a clinical trial at SCCA for patients with lung cancer with an ALK mutation. Two of the study's exclusion criteria include: less than 10 pack year smoking history (which includes me), and EGFR-negative tumors. Unfortunately, due to the insufficient tissue sample done on my CT-guided biopsy this fall, EGFR studies have not been performed on my tissue samples. Dr. M***** recommended that I have these studies done at this time to determine whether I would be eligible for this clinical trial; he stated that he suspects that I am EGFR-negative, given my poor tumor response to Tarceva, but I cannot be consented for the trial without this study. Additionally, it seems to me that these studies would be particularly indicated as I move forward with therapy, as the tumor growth over the past two months seems to indicate that I have failed second line therapy with Tarceva, and I would assume that this information would be useful in directing us for future treatments, regardless of whether I participate in the trial.

Dr. M***** was interested in discussing this with you today; he did try calling Dr. C******** while we were in the office, but unfortunately, he was out of the office. Dr. M***** did leave a voicemail, and would like to get in touch with you as soon as possible regarding this; I am also cc'ing him on this email if that is an easier method of communication for you.

I would like to proceed with this testing as soon as possible, in the next week if feasible. Dr. M***** suggested that we excise my subclavicular lymph node that had previously been biopsy positive; he noted that this would be a relatively simple procedure, and should offer plenty of tissue for all of the necessary studies. Please let me know as soon as possible if you agree with this plan and approach, as I would really like to get moving on things.
Thank you very much for your help, and I look forward to hearing from you soon.



Sincerely,

Regina Cullen

In short order, I heard back from Dr. M***** at Seattle Cancer Care:



Dear Ms Cullen



Dr C******** was kind to call me in his day off the clinic and we discussed obtaining a biopsy of the LN in your L lower neck. He told me that he will confirm that there is not enough tissue left from the previous biopsies and would organize the new procedure. We briefly discussed the possibility of you receiving therapy here in this clinical trial with a pill and he seems to think that it would be possible


I hope you have a good weekend

Then I heard back from Dr. C******** at GH:
I see Dr. Martins sent you a note about our phone call. We will try t arrange for the biopsy. The test itself takes about two to three weeks to gt an answer.
So that is where we stand.  Maybe I WILL be able to wear shorts this summer! 

If I do not test positive for the ALK therapy, we will next look at radiation and/or cyberknife treatment.  But fingers crossed for the ALK.

And I hope all of you have a good weekend as well.

Moe/Regina